Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-04

Clinical Trial Update: Role of Finerenone in African American Veterans With Diabetic Kidney Disease [Phase 4]

View source ↗

Summary

Phase 4 trial status update examining the role of finerenone in African American veterans with diabetic kidney disease; recruitment has not yet begun.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Finerenone (Kerendia) (finerenone)

Snippet

Sponsor: Washington D.C. Veterans Affairs Medical Center | Conditions: Diabetic Kidney Disease | Phase 4 | Status: NOT_YET_RECRUITING